Avalon Investment & Advisory’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
$18M Buy
226,238
+13,018
+6% +$1.04M 0.49% 57
2022
Q4
$14.4M Buy
213,220
+1,002
+0.5% +$67.8K 0.41% 85
2022
Q3
$10.6M Sell
212,218
-7,462
-3% -$372K 0.33% 97
2022
Q2
$12.2M Sell
219,680
-8,278
-4% -$461K 0.35% 90
2022
Q1
$12.7M Buy
227,958
+92,466
+68% +$5.13M 0.31% 90
2021
Q4
$7.59M Sell
135,492
-53,122
-28% -$2.98M 0.19% 108
2021
Q3
$9.05M Buy
188,614
+11,714
+7% +$562K 0.21% 112
2021
Q2
$7.41M Buy
176,900
+37,116
+27% +$1.55M 0.16% 120
2021
Q1
$4.71M Sell
139,784
-699,386
-83% -$23.6M 0.11% 134
2020
Q4
$29.3M Buy
839,170
+642
+0.1% +$22.4K 0.6% 50
2020
Q3
$29.1M Sell
838,528
-1,304
-0.2% -$45.3K 0.65% 50
2020
Q2
$27.5M Sell
839,832
-23,442
-3% -$767K 0.63% 51
2020
Q1
$26M Buy
863,274
+15,586
+2% +$469K 0.66% 43
2019
Q4
$24.5M Sell
847,688
-850
-0.1% -$24.6K 0.5% 67
2019
Q3
$21.9M Buy
848,538
+6,472
+0.8% +$167K 0.48% 65
2019
Q2
$21.5M Sell
842,066
-1,092
-0.1% -$27.9K 0.48% 66
2019
Q1
$22.1M Sell
843,158
-2,706
-0.3% -$70.8K 0.5% 64
2018
Q4
$19.5M Buy
845,864
+703,620
+495% +$16.2M 0.5% 58
2018
Q3
$3.35M Buy
142,244
+43,992
+45% +$1.04M 0.09% 193
2018
Q2
$2.27M Buy
98,252
+442
+0.5% +$10.2K 0.07% 212
2018
Q1
$2.41M Buy
97,810
+52,776
+117% +$1.3M 0.07% 197
2017
Q4
$1.21M Buy
45,034
+3,140
+7% +$84.2K 0.04% 240
2017
Q3
$1.01M Buy
41,894
+16,936
+68% +$408K 0.03% 252
2017
Q2
$535K Sell
24,958
-1,994
-7% -$42.7K 0.02% 314
2017
Q1
$462K Buy
+26,952
New +$462K 0.02% 311
2016
Q4
Sell
-51,328
Closed -$1.07M 346
2016
Q3
$1.07M Sell
51,328
-3,348
-6% -$69.6K 0.04% 205
2016
Q2
$1.47M Buy
54,676
+24,262
+80% +$652K 0.06% 154
2016
Q1
$824K Buy
30,414
+5,716
+23% +$155K 0.04% 170
2015
Q4
$717K Buy
+24,698
New +$717K 0.03% 180
2013
Q4
Sell
-22,360
Closed -$378K 188
2013
Q3
$378K Buy
22,360
+110
+0.5% +$1.86K 0.02% 161
2013
Q2
$345K Buy
+22,250
New +$345K 0.02% 173